These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22229571)

  • 21. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for cystic fibrosis.
    Mueller C; Flotte TR
    Clin Rev Allergy Immunol; 2008 Dec; 35(3):164-78. PubMed ID: 18600482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for cystic fibrosis: an example for lung gene therapy.
    Griesenbach U; Geddes DM; Alton EW
    Gene Ther; 2004 Oct; 11 Suppl 1(Suppl 1):S43-50. PubMed ID: 15454956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway epithelium directed gene therapy for cystic fibrosis.
    White AF; Ponnazhagan S
    Med Chem; 2006 Sep; 2(5):499-503. PubMed ID: 17017989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic Fibrosis Gene Therapy in the UK and Elsewhere.
    Griesenbach U; Pytel KM; Alton EW
    Hum Gene Ther; 2015 May; 26(5):266-75. PubMed ID: 25838137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and strategies for cystic fibrosis lung gene therapy.
    Koehler DR; Hitt MM; Hu J
    Mol Ther; 2001 Aug; 4(2):84-91. PubMed ID: 11482978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on Genetic Medicine for Cystic Fibrosis.
    Smirnikhina SA
    Curr Gene Ther; 2022; 22(5):386-396. PubMed ID: 35864800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out.
    Parsons D; Donnelley M
    Hum Gene Ther; 2020 Sep; 31(17-18):973-984. PubMed ID: 32718206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifier gene studies to identify new therapeutic targets in cystic fibrosis.
    Dorfman R
    Curr Pharm Des; 2012; 18(5):674-82. PubMed ID: 22229572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
    Cmielewski P; Donnelley M; Parsons DW
    J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
    Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
    Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of gene therapy trials in CF patients.
    Davies JC; Alton EW
    Methods Mol Biol; 2011; 741():55-68. PubMed ID: 21594778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technology evaluation: cystic fibrosis therapy, Genzyme.
    Cockett MI
    Curr Opin Mol Ther; 1999 Apr; 1(2):279-83. PubMed ID: 11715952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
    Guggino WB; Cebotaru L
    Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of gene therapy for cystic fibrosis pulmonary disease.
    Kennedy MJ
    Am J Respir Med; 2002; 1(5):349-60. PubMed ID: 14720037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.